Small-cap biotech stock Amarin was cleared for takeoff in March on the heels of positive commentary from Wall Street and a better-than-expected earnings report. Find out if shares can rally even higher.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.